Cargando…
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment With FOLFIRINOX: A Single-Center Retrospective Analysis
INTRODUCTION: The role of primary prophylaxis (PP) with granulocyte colony-stimulating factor (G-CSF) for patients with metastatic pancreatic adenocarcinoma (MPA) treated with FOLFIRINOX is unknown. We aimed to compare the frequencies of grades 3 or 4 neutropenia (G3/4N) and febrile neutropenia (FN)...
Autores principales: | Carvalho de Brito, Angelo Borsarelli, Riechelmann, Rachel P, Fonseca de Jesus, Victor Hugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829887/ https://www.ncbi.nlm.nih.gov/pubmed/36592369 http://dx.doi.org/10.1177/10732748221149543 |
Ejemplares similares
-
Current Treatment of Potentially Resectable Pancreatic Ductal
Adenocarcinoma: A Medical Oncologist’s Perspective
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2023) -
A Modified Regimen of 21-day Nab-Paclitaxel Plus Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Real-World Study
por: Chang, Chen, et al.
Publicado: (2022) -
Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery
por: Søreide, Kjetil, et al.
Publicado: (2023) -
Surgical Treatment of Pancreatic Cancer: Currently Debated Topics on Vascular Resection
por: Pedrazzoli, Sergio
Publicado: (2023) -
Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)
por: Bryant, JM, et al.
Publicado: (2023)